MD Anderson

Sawyer Biliary Pancreatic SymposiumDecember 3, 2016MD Anderson, Dan L. Duncan BuildingConference Center, Floor 81155 Pressler StreetHouston, Texas

Program ChairsJeffrey H. Lee, MD, MPHManoop Bhutani, MD

Goal The goal of this symposium is to understand how cholangiocarcinoma and

other biliary pancreatic cancers can be best managed by clinicians in this

area. During this international symposium, the experts from various regions

of the world will share the findings of their research, clinical experience, and

recommendations regarding these cancers. We expect this symposium will

change the practice of the attendees who will acquire the state-of-the-art

clinical information about the diseases, thus improving the overall survival

of patients with the diseases.

Educational Objectives After attending the conference, participants should be able to

• Apply the best strategy to establish accurate and prompt diagnosis to

improve patient outcomes (Knowledge, Competence, Performance, Patient

Outcomes);

• Perform appropriate endoscopic procedures (Knowledge, Competence,

Performance);

• Interpret the strengths and limitations of different approaches in

managing biliary obstruction (Knowledge, Competence);

• Incorporate the best available chemotherapy regimen and radiation

treatment in patient care (Knowledge, Competence, Performance);

• Assess surgical candidates and provide appropriate referral to the

specialty in a timely manner to improve patient outcomes (Knowledge,

Competence, Performance, Patient Outcomes).

MD Anderson

Sawyer Biliary Pancreatic Symposium

December 3, 2016

Educational Methods Lectures – Panel Discussions – Case Studies - Question and Answer Sessions

Target Audience This symposium should be of value to gastroenterologists, medical

oncologists, surgeons, interventional radiologists, and internists.

Evaluation A course evaluation form will provide participants with the opportunity to

comment on the value of the program content to their practice decisions,

performance improvement activities, or possible impact on patient health

status. Participants will also have the opportunity to comment on any

perceived commercial bias in the presentations as well as to identify future

educational topics.

Accreditation/Credit DesignationPhysicians The University of Texas MD Anderson Cancer Center is accredited by the

Accreditation Council for Continuing Medical Education (ACCME) to

provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live

activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of

their participation in the activity.

MD Anderson Program Planning CommitteeProgram ChairsJeffrey H. Lee, MD, MPHProfessorGastroenterology, Hepatology & Nutrition

Manoop Bhutani, MDProfessorGastroenterology, Hepatology & Nutrition

Committee MembersBoris Blechacz, MD, PhDAssistant ProfessorGastroenterology, Hepatology & Nutrition

Milind Javle, MDProfessorGI Medical Oncology

Selvi Thirumurthi, MDAssociate ProfessorGastroenterology, Hepatology & Nutrition

J. Nicolas Vauthey, MDProfessorSurgical Oncology

James C. Yao, MDChair and ProfessorGI Medical Oncology

Carol CoxProgram CoordinatorGastroenterology, Hepatology & Nutrition

Constance C. Tierney, CMPManagerCME/Conference Management

Certificates awarding AMA PRA Category 1 CreditTM or certificates

documenting attendance will be distributed to participants as they depart

the symposium. To obtain a CME certificate, physicians must submit a

completed evaluation questionnaire and a CME Verification Form.

Upon request, a record of attendance (certificate) will be provided on-site to

other health care professionals for requesting credits in accordance with state

nursing boards, specialty societies, or other professional associations.

We appreciate SCHOLARSHIPS FROM

John Stroehlein Distinguished Professorship

and Charles Butt

and H-E-B Gastrointestinal Cancer

Prevention, Research, and Education Program

for trainees, endoscopy nurses and

technicians, MLPs and endoscopy research teams

to benefit from this program.

H-E-B Gastrointestinal Cancer Prevention, Research,

and Education Program is an endowment to

The University of Texas MD Anderson Cancer Center.

If interested in applying for this scholarship, which covers registration to the symposium,

please check the box on the registration form.

ProgramSaturday, December 3, 2016

CHOLANGIOCARCINOMA IIModerators: Isaac L. Raijman, MD; Sandeep Lahoti, MD

10:30 A Systematic Approach to Effective Biliary Drainage in Cholangiocarcinoma Dong Wan Seo, MD, PhD

10:45 Let’s Look into the Bile Duct - Cholangioscopy Venkataraman Raman Muthusamy, MD

11:00 Who Should We Refer to Interventional Radiology for Biliary Drainage? Joshua D. Kuban, MD

11:15 Innovative Endoscopic Management of Cholangiocarcinoma Dong Ki Lee, MD, PhD

11:30 Questions and Answers With Panel Noon Lunch (Provided)

CHOLANGIOCARCINOMA & PANCREATIC CANCERModerators: Nirav Thosani, MD; Andrew Dupont, MD

1:00 p.m. Compare and Contrast: Biliary Drainage by ERCP vs Percutaneous Approach Brian Weston, MD

1:15 Is Local Endotherapy Effective for Cholangiocarcinoma? David Carr-Locke, MD

1:30 Should Intrahepatic Cholangiocarcinoma Be Considered for Liver Transplantation?

R. Mark Ghobrial, MD, PhD

1:45 Advances in Endoscopic Biliary Drainage for Pancreatic Cancer Priya A. Jamidar, MD

2:00 Endoscopic Gastrojejunostomy – Is This Ready for Prime Time Yet? Todd Baron, MD

7:00 a.m. Registration/Exhibits/Continental Breakfast

7:50 Welcome and Introduction of Mr. Kenneth Sawyer & Ms. Becky Sawyer Jeffrey H. Lee, MD, MPH

Welcoming Remarks Manoop Bhutani, MD

CHOLANGIOCARCINOMA IModerators: Gottumukkala S. Raju, MD; William A. Ross, MD

8:00 Difficulties in Establishing the Diagnosis and Managing Perihilar Cholangiocarcinoma

Jeffrey H. Lee, MD, MPH

8:15 The Conundrums and Challenges in Managing Cholangiocarcinoma at the Community Hospital

Harish K. Gagneja, MD

8:30 The Promise of Advanced Imaging Eric P. Tamm, MD

8:45 The Changing Epidemiology of Biliary Tract Malignancies and Evaluation of Staging System for Cholangiocarcinoma

Boris Blechacz, MD, PhD

9:00 The Role of Neoadjuvant/Adjuvant Therapies in Patients with Resectable Cholangiocarcinoma/Genetic Sequencing/Immunotherapy

Milind Javle, MD

9:15 The Role of Radiation Therapy in Cholangiocarcinoma Sunil Krishnan, MD

9:30 Questions and Answers With Panel

10:00 Break/Exhibits

MD Anderson FacultyManoop Bhutani, MDProfessorGastroenterology, Hepatology & Nutrition

Boris Blechacz, MD, PhDAssistant ProfessorGastroenterology, Hepatology & Nutrition

Katherine Hagan, MDAssistant ProfessorAnesthesia

Milind Javle, MDProfessorGI Medical Oncology

Matthew H. Katz, MDAssociate ProfessorSurgical Oncology

Sunil Krishnan, MDProfessorRadiation Oncology

Joshua D. Kuban, MDAssistant ProfessorInterventional Radiology

Jeffrey H. Lee, MD, MPHProfessorGastroenterology, Hepatology & Nutrition

Gregg A. Staerkel, MDProfessorPathology Administration

Eric P. Tamm, MDProfessorDiagnostic Radiology – Body Imaging

Gauri R. Varadhachary, MDProfessorGI Medical Oncology

Brian Weston, MDAssociate ProfessorGastroenterology, Hepatology & Nutrition

James C. Yao, MDChair and ProfessorGI Medical Oncology

2:15 How Far Have We Stretched the Definition of Resectable Pancreatic Adenocarcinoma?

Matthew H. Katz, MD

2:30 Advances in the Management of Borderline Resectable Pancreatic Cancer Gauri R. Varadhachary, MD

2:45 Questions and Answers With Panel

3:00 Break/Exhibits

PANCREATIC DISEASEModerators: Waqar Qureshi, MD; Mohamed O. Othman, MD

3:30 Pancreatic Neuroendocrine Tumor: Who, When and How to Treat James C. Yao, MD

3:45 Have We Made Any Progress in Establishing a Diagnosis in Pancreatic Cysts? Harry R. Aslanian, MD

4:00 Advances in Cytopathology in Biliary Pancreatic Diseases Gregg A. Staerkel, MD

4:15 Do We Have Enough Guidelines in the Management of Pancreatic Cysts? Manoop Bhutani, MD

4:30 The Art of Sedation for Endoscopic Procedures Katherine Hagan, MD

4:45 Questions and Answers With Panel 5:00 p.m. Closing Remarks/Adjourn

ModeratorsAndrew Dupont, MDAssociate ProfessorUT Health Science CenterHouston, Texas

Sandeep Lahoti, MDDigestive Associates of Houston PAClinical Assistant ProfessorGastroenterologyBaylor College of MedicineHouston, Texas

Mohamed O. Othman, MDDirector of Advanced EndoscopyAssistant Professor of MedicineBaylor College of MedicineHouston, Texas

Waqar Qureshi, MDChief of EndoscopyProfessorBaylor College of MedicineHouston, Texas

Gottumukkala S. Raju, MDJohn Stroehlein Distinguished ProfessorGastroenterology, Hepatology & NutritionMD AndersonHouston, Texas

Isaac L. Raijman, MDGastroenterologistGreater Houston GastroenterologyHouston, Texas

William A. Ross, MDProfessorGastroenterology, Hepatology & NutritionMD AndersonHouston, Texas

Nirav Thosani, MDAssistant ProfessorUT Health Science CenterHouston, Texas

Guest FacultyHarry R. Aslanian, MDAssociate Professor of MedicineYale Digestive DisordersNew Haven, Connecticut

Todd Baron, MDProfessorMedicine – GastroenterologyUniversity of North Carolina at Chapel HillChapel Hill, North Carolina

David Carr-Locke, MDProfessor of MedicineGastroenterologyMount Sinai Beth IsraelBoston, Massachusetts

Harish K. Gagneja, MDGastroenterologistAustin Gastroenterology, P.A.Austin, Texas

R. Mark Ghobrial, MD, PhDDirector of Liver Transplant ProgramHouston MethodistHouston, Texas

Priya A. Jamidar, MDProfessor of MedicineDirector, EndoscopyYale Digestive DisordersNew Haven, Connecticut

Dong Ki Lee, MD, PhDProfessor and DirectorYonsei University School of MedicineSeoul, Korea

Venkataraman R. Muthusamy, MDClinical Professor of MedicineDigestive Disease – WestwoodUniversity of California Los AngelesLos Angeles, California

Dong Wan Seo, MD, PhDProfessorDepartment of GastroenterologyUniversity of Ulsan Medical CollegeAsian Medical CenterSongpa-Gu, Seoul, Korea

Special Assistance

Contact the Department of CME/Conference Management at 713-792-2223 or toll free at 866-849-5866 if you have any special dietary or ADA accommodation needs.

Accommodations

• A block of rooms has been reserved for conference attendees at the Houston Marriott Medical Center, 6580 Fannin Street, Houston, Texas.

• Early hotel reservation is suggested. To make reservations, please call Reservations at 713-796-0080 and identify yourself as part of the Sawyer - MD Anderson Biliary Pancreatic Symposium.

• The special meeting rate is $99.00 single or double occupancy. Please add 17% Texas State and local taxes. Reservations and deposits received after November 11, 2016 will be confirmed if space is available and at current hotel published guest room rates.

Ground Transportation

• Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU).

• Taxicabs are available at an estimated cost for $50-60, to or from William P. Hobby Airport or George Bush Intercontinental Airport.

• Super Shuttle operates a shuttle bus between George Bush Intercontinental Airport and the Houston Marriott Medical Center for $27 one-way and $54 round-trip. For more information, call 713-523-8888 or toll-free at 800-258-3826 or on-line at www.supershuttle.com.

• Super Shuttle operates a shuttle bus between William P. Hobby Airport and the Houston Marriott Medical Center for $24 one-way and $48 round-trip. For more information, call 713-523-8888 or toll-free at

Physician Payments Sunshine Act

MD Anderson complies with the Physician Payments Sunshine Act as part of the Affordable Car Act (ACA). Accordingly we may be required to collect information on transfer of value provided to any covered recipient under the ACA.

Registration InformationOn-site registration opens at 7:00 a.m. on Saturday, December 3, 2016. The symposium will begin at 7:50 am on Saturday, December 3, 2016, and adjourn at 5:00 p.m. Advance registration is encouraged as space and materials are limited. Please see the registration form for applicable fees.

The full conference registration fee includes the tuition, program syllabus, continental breakfast, breaks, and lunch.

The deadline for advanced registration is Friday, November 11, 2016.

There are three ways to register:1. On-line at www.mdanderson.org/conferences2. Mail to: CME/Conference Management – Unit 1781 The University of Texas MD Anderson Cancer Center P.O. Box 301407, Houston, TX 77230-14073. Fax to: 713-794-1724

When registering online a confirmation letter will be automatically e-mailed to the e-mail address you list on the registration form. If you register by fax or mail, a receipt/confirmation letter will be sent to you within ten working days of receipt of your registration.

The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form. In case of activity cancellation, the liability of the Department of CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee.

The Department of CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

CO

NFE

RE

NC

E R

EG

IST

RA

TIO

N -

116

347

MD

And

erso

n –

Saw

yer B

iliar

y Pa

ncre

atic

Sym

posi

umDe

cem

ber 3

, 201

6TH

IS IS

NOT

A S

ELF-

MAI

LER

ADDR

ESS

TO:

MD A

nders

on –

Sawy

er Bil

iary P

ancre

atic S

ympo

sium

Depa

rtmen

t of C

ME/

Conf

eren

ce M

anag

emen

t–Un

it 17

81Th

e Un

iver

sity

of T

exas

MD

Ande

rson

Can

cer C

ente

rPO

Box

301

407,

Hou

ston

, TX

7723

0-14

07 o

r fax

to 7

13-7

94-1

724

Mak

e ch

eck

or m

oney

ord

er p

ayab

le to

:Th

e Un

iver

sity

of T

exas

MD

Ande

rson

Can

cer C

ente

r

REG

ISTR

ATI

ON

FEE

S:

1 Physicians

. . . .

. . . .

. . . .

. . . .

. . . .

. . . .

. . . .

. . . .

. . .$

501

Students/Fellows/Re

sidents

. . . .

. . . .

. . . .

. . . .

. . .$

25

1 I w

ould

like

to a

pply

for t

he J

ohn

Stro

ehle

in D

istin

guish

ed

Prof

esso

rshi

p Sc

hola

rshi

p

Last

Nam

eFi

rst

MI

High

est D

egre

e

Depa

rtmen

t (in

clud

e un

it no

.) Sp

ecia

lty

Inst

itutio

n

MD

Ande

rson

Em

ploy

ee ID

No.

(req

uire

d fo

r all

MDA

CC e

mpl

oyee

s):

Phys

icia

n Y

es

No

Stre

et

City

Stat

e/Fo

reig

n Co

untry

/Zip

or M

ail C

ode

Dayt

ime

Phon

e (w

ith a

rea

code

) Ce

ll Ph

one

(with

are

a co

de)

Fax

(with

are

a co

de)

E-m

ail A

ddre

ss (p

leas

e pr

int)

Emer

genc

y Co

ntac

tPh

one

(with

are

a co

de)

Cred

it Ca

rd H

olde

r Nam

e (F

irst/

Last

) Ch

arge

the

follo

win

g: V

ISA

MC

AM

EX

Cred

it Ca

rd N

umbe

rEx

pira

tion

Date

Secu

rity

Code

/CVV

/CSV

Cred

it Ca

rd H

olde

r Bill

ing

Addr

ess

& Z

IP C

ode

MD

And

erso

n In

terd

epar

tmen

tal T

rans

fer (

IDT)

No.

: *Fu

nd G

roup

90

will

not

be

acce

pted

Bus

ines

s U

nit

Dep

artm

ent

Fund

Gro

up*

Fund

Fund

Typ

e

Aut

hori

zed

Sign

atur

e RE

QU

IRED

for C

RED

IT C

ARD

or I

DT

IDT

Appr

over

Nam

e (F

irst/L

ast)

plea

se p

rint

The University of Texas MD Anderson Cancer Center has implemented

a process whereby everyone who is in a position to control the

content of an educational activity must disclose all relevant financial

relationships with any commercial interest that could potentially

affect the information presented. MD Anderson also requires that all

faculty disclose any unlabeled use or investigational use (not yet

approved for any purpose) of pharmaceutical and medical device

products. Specific disclosure will be made to the participants prior to

the educational activity.

Agendas are subject to change because we are always striving to

improve the quality of your educational experience. MD Anderson

may substitute faculty with comparable expertise on rare occasions

necessitated by illness, schedule conflicts, and so forth.

Photographing, audio taping and videotaping are prohibited.

Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax or e-mail CME/Conference Management. All responses will be forwarded to the Program Chairs for consideration.

Depa

rtmen

t of C

ME/

Conf

eren

ce M

anag

emen

t - U

nit 1

781

The

Univ

ersi

ty o

f Tex

as M

D An

ders

on C

ance

r Cen

ter

#176

700/

30/1

1634

7/41

Hous

ton,

TX

7723

0-14

07

Non

-Pro

fit O

rg.

U.S.

Pos

tage

PAID

Perm

it N

o. 7

052

Hous

ton,

TX